653 related articles for article (PubMed ID: 2659701)
1. Vaccination and skin test studies on children living in villages with differing endemicity for leprosy and tuberculosis.
Ghazi Saidi K; Stanford JL; Stanford CA; Dowlati Y; Farshchi Y; Rook GA; Rees RJ
Int J Lepr Other Mycobact Dis; 1989 Mar; 57(1):45-53. PubMed ID: 2659701
[TBL] [Abstract][Full Text] [Related]
2. Vaccination and skin test studies on the children of leprosy patients.
Stanford JL; Stanford CA; Ghazi Saidi K; Dowlati Y; Weiss SF; Farshchi Y; Madlener F; Rees RJ
Int J Lepr Other Mycobact Dis; 1989 Mar; 57(1):38-44. PubMed ID: 2659700
[TBL] [Abstract][Full Text] [Related]
3. A pilot study of three potential vaccines for leprosy in Bombay.
Ganapati R; Revankar CR; Lockwood DN; Wilson RC; Price JE; Ashton P; Ashton LA; Holmes RM; Bennett C; Stanford JL
Int J Lepr Other Mycobact Dis; 1989 Mar; 57(1):33-7. PubMed ID: 2659699
[TBL] [Abstract][Full Text] [Related]
4. Sensitization potential and reactogenicity of BCG with and without various doses of killed Mycobacterium leprae.
Gupte MD; Anantharaman DS; De Britto RL; Vallishayee RS; Nagaraju B; Kannan S; Sengupta U
Int J Lepr Other Mycobact Dis; 1992 Sep; 60(3):340-52. PubMed ID: 1474275
[TBL] [Abstract][Full Text] [Related]
5. Anti-leprosy protective vaccination of rhesus monkeys with BCG or BCG plus heat-killed Mycobacterium leprae: lepromin skin test results.
Gormus BJ; Baskin GB; Xu K; Ratterree MS; Mack PA; Bohm RP; Meyers WM; Walsh GP
Lepr Rev; 2002 Sep; 73(3):254-61. PubMed ID: 12449891
[TBL] [Abstract][Full Text] [Related]
6. Regional lymphadenitis following antileprosy vaccine BCG with killed Mycobacterium leprae.
De Britto RL; Ramanathan VD; Gupte MD
Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):12-9. PubMed ID: 9207749
[TBL] [Abstract][Full Text] [Related]
7. Randomised controlled trial of single BCG, repeated BCG, or combined BCG and killed Mycobacterium leprae vaccine for prevention of leprosy and tuberculosis in Malawi. Karonga Prevention Trial Group.
Lancet; 1996 Jul; 348(9019):17-24. PubMed ID: 8691924
[TBL] [Abstract][Full Text] [Related]
8. Delayed-type hypersensitivity, mycobacterial vaccines and protective immunity.
Fine PE; Sterne JA; Pönnighaus JM; Rees RJ
Lancet; 1994 Nov; 344(8932):1245-9. PubMed ID: 7967984
[TBL] [Abstract][Full Text] [Related]
9. Sensitization studies with potential leprosy vaccine preparations in northern Malawi.
Ponnighaus JM; Fine PE
Int J Lepr Other Mycobact Dis; 1986 Mar; 54(1):25-37. PubMed ID: 3519803
[TBL] [Abstract][Full Text] [Related]
10. Skin test studies on close contacts of leprosy patients in India.
Lord R; Naish C; Taylor C; Stanford CA; Stanford CJ; Chacko JG; Debanbu V; Samson PD; Berchmans J; Surendran D
Int J Lepr Other Mycobact Dis; 1989 Dec; 57(4):801-9. PubMed ID: 2809346
[TBL] [Abstract][Full Text] [Related]
11. Antileprosy protective vaccination of sooty mangabey monkeys with BCG or BCG plus heat-killed Mycobacterium leprae: immunologic observations.
Gormus BJ; Baskin GB; Xu K; Ratterree MS; Martin LN; Mack PA; Bohm RP; Meyers WM; Walsh GP
Int J Lepr Other Mycobact Dis; 2000 Dec; 68(4):434-43. PubMed ID: 11332286
[TBL] [Abstract][Full Text] [Related]
12. Antileprosy protective vaccination of rhesus monkeys with BCG or BCG plus heat-killed Mycobacterium leprae: immunologic observations.
Gormus BJ; Baskin GB; Xu K; Ratterree MS; Martin LN; Mack PA; Bohm RP; Meyers WM; Walsh GP
Int J Lepr Other Mycobact Dis; 2000 Mar; 68(1):27-39. PubMed ID: 10834067
[TBL] [Abstract][Full Text] [Related]
13. Tuberculin sensitivity and skin lesions in children after vaccination with two batches of BCG vaccine.
Vallishayee RS; Anantharaman DS; Gupte MD
Indian J Lepr; 1998; 70(3):277-86. PubMed ID: 9801900
[TBL] [Abstract][Full Text] [Related]
14. Sensitization potential and reactogenicity of varying doses of BCG plus killed Mycobacterium leprae: an extended study.
Gupte MD; Vallishayee RS; De Britto LJ; Anantharaman DS
Int J Lepr Other Mycobact Dis; 1993 Dec; 61(4):563-70. PubMed ID: 8151187
[TBL] [Abstract][Full Text] [Related]
15. A study of cellular immunity in clinically healthy children of parents with leprosy in northern Thailand.
Nelson KE; Speck SM; Suprasert S; Smith T
Int J Lepr Other Mycobact Dis; 1984 Jun; 52(2):147-53. PubMed ID: 6539306
[TBL] [Abstract][Full Text] [Related]
16. Immunoprophylactic trial with combined Mycobacterium leprae/BCG vaccine against leprosy: preliminary results.
Convit J; Sampson C; Zúñiga M; Smith PG; Plata J; Silva J; Molina J; Pinardi ME; Bloom BR; Salgado A
Lancet; 1992 Feb; 339(8791):446-50. PubMed ID: 1346818
[TBL] [Abstract][Full Text] [Related]
17. [Novel vaccines against M. tuberculosis].
Okada M
Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
[TBL] [Abstract][Full Text] [Related]
18. [Evaluation of tuberculin reactivity in different age groups with and without BCG vaccination].
Yildirim C; Küçük AI; Ongüt G; Oğünç D; Colak D; Mutlu G
Mikrobiyol Bul; 2009 Jan; 43(1):27-35. PubMed ID: 19334377
[TBL] [Abstract][Full Text] [Related]
19. [Eradication of leprosy and public health. Vaccination and multidrug therapy].
Janaszek W
Przegl Epidemiol; 2002; 56(4):577-86. PubMed ID: 12666583
[TBL] [Abstract][Full Text] [Related]
20. Immunoprophylactic effects of the anti-leprosy Mw vaccine in household contacts of leprosy patients: clinical field trials with a follow up of 8-10 years.
Sharma P; Mukherjee R; Talwar GP; Sarathchandra KG; Walia R; Parida SK; Pandey RM; Rani R; Kar H; Mukherjee A; Katoch K; Benara SK; Singh T; Singh P
Lepr Rev; 2005 Jun; 76(2):127-43. PubMed ID: 16038246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
